UB06:LSE:LSE-UBS MSCI EMU UCITS EUR A-dis (GBX)

ETF | Others |

Last Closing

USD 14022

Change

0.00 (0.00)%

Market Cap

USD 0.51B

Volume

120.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R15:LSE SoftBank Group Corp.

N/A

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

-0.43 (0.00%)

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

-1.75 (-0.94%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.17%)

USD 642.91B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.02 (+0.10%)

USD 636.40B
0R1I:LSE NVIDIA Corp.

-3.70 (-0.39%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

-13.50 (-0.66%)

USD 320.04B
0QZK:LSE Coca-Cola Co.

-0.40 (-0.63%)

USD 266.08B
0QZO:LSE 0QZO

-0.40 (-0.39%)

USD 258.54B

ETFs Containing UB06:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.85% 71% C- 68% D+
Dividend Return 0.00% 1% F 3% F
Total Return 6.85% 70% C- 67% D+
Trailing 12 Months  
Capital Gain 9.16% 52% F 59% D-
Dividend Return 0.00% 10% F 5% F
Total Return 9.16% 51% F 59% D-
Trailing 5 Years  
Capital Gain 32.85% 55% F 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.85% 52% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 6.12% 58% F 63% D
Dividend Return 6.12% 57% F 62% D
Total Return 0.00% 53% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 14.04% 53% F 67% D+
Risk Adjusted Return 43.62% 62% D 74% C
Market Capitalization 0.51B 70% C- 60% D-

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike